{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:51:20Z","timestamp":1791960680813,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ajo.2007.12.030","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T17:58:14Z","timestamp":1204826294000},"page":"875-878.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Intravitreal Bevacizumab for Choroidal Neovascularization in Ocular Histoplasmosis"],"prefix":"10.1016","volume":"145","author":[{"given":"Ramin","family":"Schadlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Blinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav K.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Holekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gilbert","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Engelbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra S.","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita G.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsham","family":"Sheybani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.12.030_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.icu.0000188321.61101.93","article-title":"Presumed ocular histoplasmosis syndrome","volume":"16","author":"Prasad","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib2","series-title":"Ocular Infection and Immunity","first-page":"1252","article-title":"Histoplasmosis","author":"Brown","year":"1996"},{"key":"10.1016\/j.ajo.2007.12.030_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00006982-198808040-00001","article-title":"Subfoveal neovascularization in the ocular histoplasmosis syndrome: a natural history study","volume":"8","author":"Kleiner","year":"1988","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.12.030_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00055735-200112000-00009","article-title":"Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies","volume":"12","author":"Ciulla","year":"2001","journal-title":"Curr Opin Opthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archopht.1997.01100150269022","article-title":"Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration","volume":"115","author":"Spraul","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib6","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/archopht.1987.01060110045029","article-title":"Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial","volume":"105","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archopht.122.11.1597","article-title":"Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(02)01103-X","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series","volume":"109","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.12.030_bib9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ophtha.2004.02.014","article-title":"Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label two-year study","volume":"111","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.12.030_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00006982-200306000-00003","article-title":"Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome","volume":"23","author":"Busquets","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.12.030_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006982-200412000-00004","article-title":"Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series","volume":"24","author":"Liu","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.12.030_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/09273940590951124","article-title":"Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like)","volume":"13","author":"Postelmans","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2007.12.030_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00006982-200501000-00003","article-title":"Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome","volume":"25","author":"Shah","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.12.030_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ajo.2006.05.061","article-title":"Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases","volume":"142","author":"Kaiser","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00417-007-0636-z","article-title":"Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin)","volume":"245","author":"Ahmadieh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","article-title":"Proper method for calculating average visual acuity","volume":"13","author":"Holladay","year":"1997","journal-title":"J Refract Surg"},{"key":"10.1016\/j.ajo.2007.12.030_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","article-title":"Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome","volume":"136","author":"Rechtman","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajo.2004.10.005","article-title":"The safety profile of long-term, high-dose intraocular corticosteroid delivery","volume":"139","author":"Holekamp","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.12.030_bib20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","article-title":"Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization","volume":"110","author":"Spaide","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.12.030_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","article-title":"Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:56:31Z","timestamp":1757595391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939408000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0002939408000093"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.12.030","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Bevacizumab for Choroidal Neovascularization in Ocular Histoplasmosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}